Full implementation of electronic product information (ePI) on medicines in the EU may not be achieved until 2030, according to a survey conducted by the European R&D-based pharmaceutical industry federation, EFPIA.
As part of the shift to ePI, a pilot scheme in Belgium and Luxembourg on switching from paper to electronic patient information leaflets (e-PILs) has been extended to August 2022 on the back of positive interim results showing that the vast majority of